Immune-based approaches that could block the development of skin cancer by boosting immunity against the commensal HPVs present in all of our skin nature.com/articles/s41586-0…
PathoVax retweeted
.@PathoVax is an early stage biotech start-up company that was spun out of .@JohnsHopkins (& a .@MDTEDCO portfolio company). Vision: Develop a new generation of safe, efficacious medicines for the prevention & treatment of emerging infectious disease & cancers. Join them today!
We’re pleased to have a presence back in Boston as part of the @JLABS family #JPODSBoston #innovation – at Cambridge, MA
PathoVax retweeted
Congrats to the leaders of @Sonavex, @SisuGlobal, @GemstoneBio, @PathoVax, Avidea Technologies, @the_clearmask and Renalert for being named some of Baltimore's Top 10 BioHealth Startup CEOs by @BioBuzzMaryland! bddy.me/2UqSQFa
PathoVax will be at #AACR2019!! Come check out our late breaking poster presentation this Tuesday morning (April 2nd) on our next generation HPV vaccine! Poster#18 Section #42 – at Atlanta, GA
PathoVax retweeted
Congratulations to @MDTEDCO #MII portfolio company @PathoVax on successful strides towards #vaccine commercialization
PathoVax secures another SBIR Ph1 worth $300K from the NCI to imbue thermostable and single-dose properties into our HPV vaccine-RGVax. This new formulation will potentiate the world’s 1st single- immunization, thermostable, broad-spectrum Human Papillomavirus (HPV) Vaccine!! – at Baltimore, MD
PathoVax LLC is looking to hire! Contact us if you or someone you know might be a fit for either our Platform Discovery Scientist/Sr Scientist or Research Associate Scientist positions!! lnkd.in/dKBZEuV – at Baltimore, MD
PathoVax retweeted
Vaccination with #HPV vaccines is the best way to prevent several types of cancer, including some throat cancers: cancer.gov/about-cancer/caus…
1st PathoVax Annual Christmas Party! 🎄 Here’s to many more years to come! #Christmas #TeamPhoto #Vaccines #GrowingTeam – at Gaithersburg, MD
PathoVax retweeted
Congrats PathoVax!! JHU startup PathoVax raises $2.75M, grows team technical.ly/baltimore/2018/… via @TechnicallyBMR
PathoVax retweeted
#MTCVMS Mentee Company and JHU startup PathoVax raises $2.75M, grows team buff.ly/2CSsaZL via @TechnicallyBMR @PathoVax
PathoVax retweeted
Congrats @PathoVax 🙌
JHU startup PathoVax raises $2.75 million as it works toward human trials of its HPV vaccine bit.ly/2EtsgIH
Another article about our Series A1! Looking forward to achieving success! technical.ly/baltimore/2018/… – at Baltimore, MD
Today’s #IPVC2018 plenary lecture! Acting Director of NCI Doug Lowy mentions the RG-1 VLP technology as a promising approach to target neglected HPV types !! #FightHPVTogether – at Sydney, New South Wales
We’re here at the #IPVC2018! If you missed our talk yesterday! No worries, Check out our poster or remaining talk on our vaccine antibody mechanism of protection this Saturday!#FightHPVTogether – at Sydney, New South Wales
PathoVax retweeted
Congrats! teapawt.net/PathoVax/status/101454…
Happy 4th of July! As fireworks light up the sky to celebrate Independence Day! We are celebrating our own brand new independent private lab space @FastForward_U ! #july4th #independenceday #independentlab #entrepreneurlife #MD #JohnsHopkins #Milestones #GrowingUp



























